{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:04:03Z","timestamp":1782842643000,"version":"3.54.5"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Acute retinal necrosis (ARN) is an inflammatory disease that is primarily caused by herpesvirus infection, most commonly varicella-zoster virus (VZV), followed by herpes simplex virus (HSV) and occasionally cytomegalovirus (CMV). Sintilimab is an immune checkpoint inhibitor (ICI) that can enhance the body\u2019s anti-tumor immune response. However, treatment with ICIs may lead to reactivation of the VZV. Here, we present a case of ARN caused by VZV infection in a patient receiving sintilimab for cervical cancer. A 64-year-old female patient developed vision loss and floaters with left eye redness for one week after 22 cycles of sintilimab for cervical cancer. Based on clinical manifestations, ophthalmological examination, and vitreous humor biopsy, the patient was diagnosed with acute retinal necrosis syndrome secondary to VZV. After receiving systemic antiviral and anti-inflammatory therapy, retinal necrosis lesions and visual function improved. In conclusion, clinicians should be aware of the risk of ARN when using sintilimab and should actively monitor patients for prompt diagnosis and optimal management of this rare adverse drug reaction.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1301329","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T04:12:12Z","timestamp":1705983132000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute retinal necrosis in a patient with cervical malignant tumor treated with sintilimab: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Pei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianting","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40942-022-00417-w","article-title":"Acute retinal necrosis. Management and visual outcomes: a case series","volume":"8","author":"Mojarrad","year":"2022","journal-title":"Int J retina vitreous"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.03.057","article-title":"Classification criteria for acute retinal necrosis syndrome","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12020386","article-title":"Acute retinal necrosis: signs, treatment, complications and outcome","volume":"12","author":"Mayer","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1624780","article-title":"Human adenovirus: an unusual causative agent for acute retinal necrosis presented with central retinal vascular occlusion","volume":"28","author":"Ozdemir","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2023.2181188","article-title":"Acute retinal necrosis associated with pseudorabies virus infection: A case report and literature review","author":"Xu","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.21037\/atm-20-4750","article-title":"The dark side of immunotherapy","volume":"9","author":"Okwundu","year":"2021","journal-title":"Ann Trans Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13377","article-title":"Herpes zoster granulomatous dermatitis in metastatic lung cancer treated with nivolumab: A case report","volume":"11","author":"Gozzi","year":"2020","journal-title":"Thorac cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-21-2764","article-title":"Herpes zoster in lung cancer patients treated with PD-1\/PD-L1 inhibitors","volume":"11","author":"Taoka","year":"2022","journal-title":"Trans Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.ophtha.2009.03.029","article-title":"Acute retinal necrosis: clinical features, early vitrectomy, and outcomes","volume":"116","author":"Hillenkamp","year":"2009","journal-title":"Ophthalmology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cxo.12284","article-title":"Necrotising herpetic retinopathies: a review and progressive outer retinal necrosis case report","volume":"99","author":"Ittner","year":"2016","journal-title":"Clin Exp Optom"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/BF02539407","article-title":"A comparative study of the polymerase chain reaction and local antibody production in acute retinal necrosis syndrome and cytomegalovirus retinitis","volume":"234","author":"Abe","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40942-020-00225-0","article-title":"Toxoplasmosis chorioretinitis mimicking acute retinal necrosis associated with local corticosteroid","volume":"6","author":"Crosson","year":"2020","journal-title":"Int J retina vitreous"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20151027-11","article-title":"Secondary vitreoretinal lymphoma masquerading as acute retinal necrosis","volume":"46","author":"Ryan","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"B15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bjo.2004.042226","article-title":"Necrotising retinopathies simulating acute retinal necrosis syndrome","volume":"89","author":"Balansard","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1922926","article-title":"Cytopathology of vitreous specimens in acute retinal necrosis","volume":"30","author":"Hojjatie","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.08.003","article-title":"Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome","volume":"117","author":"Wong","year":"2010","journal-title":"Ophthalmology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001920","article-title":"Case report: acute retinal necrosis after a cervical epidural steroid injection","volume":"99","author":"Kamo","year":"2022","journal-title":"Optom Vis Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_811_17","article-title":"Progressive outer retinal necrosis after rituximab and cyclophosphamide therapy","volume":"66","author":"Dogra","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211006576","article-title":"Bilateral acute retinal necrosis during treatment with alemtuzumab for multiple sclerosis","volume":"32","author":"Menean","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.5.465","article-title":"Detecting herpesvirus DNA in uveitis using the polymerase chain reaction","volume":"80","author":"Yamamoto","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.594558","article-title":"Sintilimab: A promising anti-tumor PD-1 antibody","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02091","article-title":"Efficacy and safety of sintilimab plus anlotinib for PD-L1-positive recurrent or metastatic cervical cancer: A multicenter, single-arm, prospective phase II trial","volume":"40","author":"Xu","year":"2022","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2021.1890133","article-title":"Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis","volume":"6","author":"Hou","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03498-0","article-title":"Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections","volume":"72","author":"Schmitt","year":"2023","journal-title":"Cancer Immunol Immunother CII"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113962","article-title":"Immune checkpoints contribute corneal immune privilege: implications for dry eye associated with checkpoint inhibitors","volume":"21","author":"Hori","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.11.007","article-title":"Diagnosis and treatment of acute retinal necrosis: A report by the American academy of ophthalmology","volume":"124","author":"Schoenberger","year":"2017","journal-title":"Ophthalmology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000124","article-title":"Varicella-zoster virus as a causative agent of acute retinal necrosis in younger patients","volume":"132","author":"Xu","year":"2019","journal-title":"Chin Med J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/1120672118787438","article-title":"Clinical feature and visual prognosis of acute retinal necrosis according to the initially involved zone and extent: 10-year experience","volume":"29","author":"Kim","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-021-02131-2","article-title":"Efficacy of prophylactic laser retinopexy in acute retinal necrosis: A systematic review and meta-analysis","volume":"42","author":"Fan","year":"2022","journal-title":"Int Ophthalmol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1800051","article-title":"Role of prophylactic vitrectomy in acute retinal necrosis in preventing rhegmatogenous retinal detachment: systematic review and meta-analysis","volume":"30","author":"Fan","year":"2022","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1301329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T04:12:14Z","timestamp":1705983134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1301329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2024.1301329"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1301329","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"article-number":"1301329"}}